FDA Study Suggests Kratom Capsules Safe at High Doses

In a groundbreaking preliminary study, the U.S. Food and Drug Administration has found that kratom leaves appear to be safe even at high doses when consumed in capsule form. This marks the first official research by the FDA into the popular botanical compound, which has been used for centuries in Southeast Asia.

The study aims to address the lack of scientific data surrounding kratom, which has been previously flagged as a potential public health threat. While the findings are promising for capsule users, questions remain about the safety of kratom in drinks and concentrates, which are more common in the U.S. and contain higher levels of the compound.

This research could have significant implications for the regulation and perception of kratom in the United States. The results may pave the way for further studies and potentially influence future policy decisions regarding this controversial substance.